BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 21956718)

  • 21. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
    Liu G; Byrd A; Warner AN; Pei F; Basha E; Buchanan A; Buchan JR
    Mol Cell Biol; 2020 Jan; 40(4):. PubMed ID: 31767634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
    Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
    Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered mRNP granule dynamics in FTLD pathogenesis.
    Bowden HA; Dormann D
    J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA-binding proteins with prion-like domains in ALS and FTLD-U.
    Gitler AD; Shorter J
    Prion; 2011; 5(3):179-87. PubMed ID: 21847013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
    Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
    Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72.
    McGurk L; Lee VM; Trojanowksi JQ; Van Deerlin VM; Lee EB; Bonini NM
    J Neuropathol Exp Neurol; 2014 Sep; 73(9):837-45. PubMed ID: 25111021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
    Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
    Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the prion-related Q/N domains in TDP-43 and FUS.
    Udan M; Baloh RH
    Prion; 2011; 5(1):1-5. PubMed ID: 21135580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
    Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
    Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic functions of TDP-43 and FUS and their role in ALS.
    Birsa N; Bentham MP; Fratta P
    Semin Cell Dev Biol; 2020 Mar; 99():193-201. PubMed ID: 31132467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.
    Dormann D; Haass C
    Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
    Mackenzie IR; Neumann M
    Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
    Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.
    Da Cruz S; Cleveland DW
    Curr Opin Neurobiol; 2011 Dec; 21(6):904-19. PubMed ID: 21813273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
    Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
    EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
    Lourenco GF; Janitz M; Huang Y; Halliday GM
    Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS.
    Chitramuthu BP; Kay DG; Bateman A; Bennett HP
    PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.